Content area

|
|

Kroniske pulmonale aspergilloser

Forfatter(e)
Jesper Rømhild Davidsen1, 2, 3, Flemming S. Rosenvinge4, Kristian Assing5 & Christian B. Laursen1 1) Syddansk Center for Interstitielle LungeSygdomme, Odense Universitetshospital 2) Lungemedicinsk Afdeling J, Odense Universitetshospital 3) Lungemedicinsk Forskningsenhed, Klinisk Institut, Syddansk Universitet 4) Klinisk Mikrobiologisk Afdeling, Odense Universitetshospital 5) Klinisk Immunologisk Afdeling, Odense Universitetshospital Ugeskr Læger 2018;180:V05170434
Reference: 
Ugeskr Læger 2018;180:V05170434
Blad nummer: 
Sidetal: 
2-6
Chronic pulmonary aspergillosis
Chronic pulmonary aspergillosis (CPA) is an overlooked disease category in which delay of diagnosis and treatment is associated with increased mortality. A prerequisite for prognostic optimization of CPA is an increased focus on predisposing factors and patients at risk. Diagnosis of CPA is challenging and requires a systematic approach to assessment and interpretation of findings, both of which are necessary for correct disease classification and selection of targeted antifungal treatment and duration.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Peter Tagmose Thomsen | 15/06
1 Kommentar
af Solvejg Henneberg Pedersen | 15/06
3 kommentarer
af Gorm Boje Jensen | 14/06
1 Kommentar
af Otto Brændstrup | 11/06
1 Kommentar
af Henrik Keller | 11/06
1 Kommentar
af Klaus Larsen | 06/06
2 kommentarer
af Tommie Mynster | 04/06
1 Kommentar
af Jakob Ramlau | 03/06
1 Kommentar